HRMY
Price
$31.54
Change
-$0.52 (-1.62%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
1.84B
48 days until earnings call
SAGE
Price
$9.24
Change
+$0.02 (+0.22%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
577.38M
41 days until earnings call
Interact to see
Advertisement

HRMY vs SAGE

Header iconHRMY vs SAGE Comparison
Open Charts HRMY vs SAGEBanner chart's image
Harmony Biosciences Holdings
Price$31.54
Change-$0.52 (-1.62%)
Volume$19.17K
Capitalization1.84B
Sage Therapeutics
Price$9.24
Change+$0.02 (+0.22%)
Volume$45.12K
Capitalization577.38M
HRMY vs SAGE Comparison Chart in %
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. SAGE commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a Buy and SAGE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (HRMY: $32.06 vs. SAGE: $9.22)
Brand notoriety: HRMY and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRMY: 81% vs. SAGE: 79%
Market capitalization -- HRMY: $1.84B vs. SAGE: $577.38M
HRMY [@Biotechnology] is valued at $1.84B. SAGE’s [@Biotechnology] market capitalization is $577.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, SAGE is a better buy in the long-term than HRMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 4 TA indicator(s) are bullish while SAGE’s TA Score has 5 bullish TA indicator(s).

  • HRMY’s TA Score: 4 bullish, 4 bearish.
  • SAGE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than SAGE.

Price Growth

HRMY (@Biotechnology) experienced а -1.26% price change this week, while SAGE (@Biotechnology) price change was +1.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

HRMY is expected to report earnings on Aug 12, 2025.

SAGE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($1.84B) has a higher market cap than SAGE($577M). SAGE YTD gains are higher at: 69.797 vs. HRMY (-6.829). HRMY has higher annual earnings (EBITDA): 238M vs. SAGE (-358.98M). HRMY has more cash in the bank: 507M vs. SAGE (424M). SAGE has less debt than HRMY: SAGE (11.9M) vs HRMY (176M). HRMY has higher revenues than SAGE: HRMY (745M) vs SAGE (47.4M).
HRMYSAGEHRMY / SAGE
Capitalization1.84B577M319%
EBITDA238M-358.98M-66%
Gain YTD-6.82969.797-10%
P/E Ratio12.24N/A-
Revenue745M47.4M1,572%
Total Cash507M424M120%
Total Debt176M11.9M1,479%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYSAGE
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 14 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTISX21.480.19
+0.89%
NYLI Income Builder SIMPLE Class
EQIRX12.690.04
+0.29%
Allspring Emerging Markets Eq Advtg R6
TGVNX27.86N/A
N/A
TCW Relative Value Mid Cap N
VGSNX19.99N/A
N/A
Vanguard Real Estate Index Institutional
MGORX39.61N/A
N/A
Morgan Stanley Inst Global Opp IR

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
+0.41%
SNBIF - HRMY
52%
Loosely correlated
N/A
SAGE - HRMY
39%
Loosely correlated
-0.86%
CYTK - HRMY
37%
Loosely correlated
+2.33%
ANAB - HRMY
35%
Loosely correlated
+2.19%
LGND - HRMY
32%
Poorly correlated
+2.82%
More